Abstract: The present invention relates to a gauze catalyst based on titanium or vanadium zeolites and inert gauze fabrics which is suitable for accelerating oxidation reactions such as epoxidation of olefins, hydrogen peroxide production or hydroxylamine synthesis.

Abstract: Molding materials modified with acrylic rubber are prepared by means of groups which are incorporated in the acrylic rubber and are decomposed by a redox component to give free radicals.

Abstract: Molding materials (F) which are suitable for the production of shaped articles having reduced surface gloss and are based on polymers or polymer blends (P), preferably ASA polymers and/or styrene/acrylonitrile copolymers, contain a sufficient amount of a dull graft copolymer (A) admixed as dulling agent, which was prepared by one-stage or multistage graft copolymerization of monomers forming the hard shell onto an elastomeric acrylate polymer, the graft copolymerization being carried out to a conversion of more than 15% by thermal or free radical mass or solution polymerization.

Abstract: Cyclic urea derivatives of the formula I ##STR1## in which X, X', Y, Y' and Z can have various meanings, are prepared by a) reacting a urea derivative of the formula II ##STR2## with a diketone of the formula III ##STR3## and b) hydrogenating the product from step a) in the presence of a metal-containing catalyst.

Abstract: The aqueous dispersion of a biodegradable aliphatic-aromatic polyester is useful as a binder for nonwovens and for coating paper.

Abstract: The present invention relates to an improved Skraup reaction process wherein pressure is applied during the reaction and the number of equivalents of sulfuric acid utilized is reduced.

Abstract: 1,4-Butanediol is prepared by a process which comprises converting 1,3-butadiene diepoxide in the presence of hydrogen over a hydrogenation catalyst whose active component is not elemental Pd and/or Pt. The hydrogenation catalyst preferably contains at least one element from the group Ib, VIIb or VIIIb of the Periodic Table of Elements.

Abstract: A photoinitiator blend, containinga) at least one monoacylphosphine oxide of formula I ##STR1## in which R.sup.1 denotes C.sub.1 -C.sub.18 alkyl; C.sub.1 -C.sub.4 alkyl, C.sub.5 -C.sub.8 cycloalkyl, C.sub.7 -C.sub.9 phenylalkyl, phenyl, naphthyl, biphenyl, all substituted by halogen or C.sub.1 -C.sub.6 alkoxy; phenyl, naphthyl or biphenylyl, all mono- or poly-substituted by halogen, C.sub.1 -C.sub.12 alkyl and/or C.sub.1 -C.sub.12 alkoxy; or a monovalent N--, O--, or S--containing 5-membered or 6-membered heterocyclic radical,R.sup.2 denotes phenyl, naphthyl, biphenylyl; phenyl, naphthyl or biphenylyl, all mono- or poly-substituted by halogen, C.sub.1 -C.sub.12 alkyl and/or C.sub.1 -C.sub.12 alkoxy; a monovalent N--, O--, or S--containing 5-membered or 6-membered heterocyclic radical, C.sub.1 -C.sub.18 alkoxy, phenoxy; phenoxy substituted by halogen, C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 alkoxy; benzyloxy, cyclohexyloxy or R.sup.2 and R.sup.1 form a ring together with the phosphorus atom,R.sup.

Abstract: The catalyst systems comprise as active constituentsa) a metal complex of the formula (I) ##STR1## b) one or more Lewis or protic acids or a mixture of Lewis and protic acids.

Abstract: A stable dispersion of melamine in polyol components comprising at least one relatively high molecular weight compound containing at least two reactive hydrogen atoms and, if desired, low molecular weight chain extenders and/or crosslinkers, blowing agents, catalysts, flame retardants and also further auxiliaries and/or additives is prepared by using the melamine in combination with at least one amine and at least one organic and/or modified organic isocyanate. Such a dispersion can be used for producing flame-resistant polyurethane foams.

Abstract: Herbicidal compositions containinga) at least one cyclohexenone oxime ether of the formula I ##STR1## and b) at least one of the following 44 compounds:b1) bromobutide, dimepiperate, etobenzanid, propanil,b2) anilofos, mefenacet,b3) 2,4-D, MCPB, naproanilide,b4) bentazone,b5) pyrazolynate/pyrazolate, sulcotrione,b6) esprocarb, molinate, pyributicarb, thiobencarb/benthiocarb,b7) quinclorac,b8) butachlor, butenachlor, pretilachlor, thenylchlor,b9) cycloxydim, sethoxydim,b10) pendimethalin,b11) cyhalofop-butyl, fenoxaprop-ethyl,b12) benzofenap, pyrazoxyfen,b13) dithiopyr,b14) sodium 2,6-bis[(4,6-dimethoxypyrimidin-2-yl)oxy]-benzoate and methyl 2-[(4,6-dimethoxypyrimidin-2-yl)-oxy]-6-[1-(methoxyimino)ethyl]benzoate;b15) azimsulfuron, bensulfuron-methyl, cinosulfuron, cyclosulfamuron, ethoxysulfuron, imazosulfuron, pyrazosulfuron-ethyl,b16) dimethametryn, simetryn/simetryne,b17) benfuresate,b18) cafenstrole,b19) cinmethylin,b20) piperophos,are described.

Abstract: Compounds of the general formula (I):H(--CH.sub.2 --CR.sup.1 R.sup.2).sub.m (--CH.sub.2 --CR.sup.1 R.sup.3).sub.n --H (I)whereR.sup.1 is H or methyl,R.sup.2 is --C(O)--Y--R.sup.4, where R.sup.4 is H, methyl, ethyl or allyl,R.sup.3 is --C(O)--Y--allyl andY is O or NH,orR.sup.1 is H or C.sub.1 -C.sub.20 -alkyl,R.sup.2 is H andR.sup.3 is (--CH.sub.2 --CR.sup.5 .dbd.CR.sup.6 --CH.sub.2).sub.p --H, where R.sup.5 and R.sup.6 independently are each H,methyl, ethyl or chlorine and p is 1-100,orR.sup.1 is H,R.sup.2 is OH or O-allyl andR.sup.3 is O-allyl,orR.sup.1 is H,R.sup.2 is OH or R.sup.3 andR.sup.3 is (meth)acrylate, --O--C(O)--CH.dbd.CH--COOH or --O--C(O)--CH.sub.2 --C(.dbd.CH.sub.2)--COOH,and m is an integer from 5 to 500,000 and n is an integer from 2 to 100,000, are used as crosslinking agents in particulate emulsion polymers having a glass transition temperature below 0.degree. C. and a mean particle size of from 50 to 1000 nm.

Abstract: A process for preparing tetrahydrofuran, which comprises reacting 1,4-butenediol diethers of the formulae I and/or IIRO--CH.sub.2 --CH.dbd.CH--CH.sub.2 --OR IRO--CH.sub.2 --CH.sub.2 .dbd.CH--CH.sub.2 --OR II,where the R radicals can be identical or different and are C.sub.1 -C.sub.15 -alkyl or cycloalkyl radicals, C.sub.6 -C.sub.12 -aryl radicals or C.sub.7 -C.sub.15 -aralkyl radicals, with water and hydrogen at from 20 to 300.degree. C. under from 1 to 300 bar in the presence of catalysts or catalyst combinations which comprise components which are both capable of hydrogenation and have acidic or basic centers and a novel process for preparing 1,4-butanediol diethers of the formula I by metathesis are described.The invention furthermore relates to the separate preparation of 1,4-butanediol monoethers of the formula IIIHO--CH.sub.2 --CH.sub.2 --CH.sub.2 --CH.sub.

Abstract: Thermoplastic molding compositions compriseA) from 30 to 97% by weight of a polyester,B) from 1 to 30% by weight of melamine cyanurate,C) from 1 to 30% by weight of at least one phosphorus-containing flame retardant which contains phosphorus in the valence state -1, -2 or -3,D) from 0 to 60% by weight of other additives and processing aids,where the total of the percentages by weight of components A) to D) is 100%.

Abstract: Preparing (3R, 3'R)-zeaxanthin of the formula I ##STR1## starting from (4-hydroxy-2,2,6-trimethylcyclohexanone of the formula II ##STR2## via the novel intermediates (4R,6R)-1-formyl-2,2,6-trimethyl-7-oxabicyclo[2.2.1]heptane of the formula IV ##STR3## (4R,6R)-1-(3-oxo-1-butenyl)-2,2,6-trimethyl-7-oxabicyclo[2.2.1]heptane of the formula V ##STR4## (4R,6R)-1-(3- hydroxy-3-methyl-1,4-pentadienyl)-2,2,6-trimethyl-7-oxabicyclo[2.2.1]heptan e of the formula VI ##STR5## [5-(4R,6R)-(4-hydr oxy-2,2,6-trimethyl-1-cyclohexylidene)-3-methyl-1,3-pentadienyl]triarylphos phonium salt of the formula iso-III ##STR6## where Ar is aryl and X is one equivalent of an anion of a strong acid. The (4R,6R)-1-formyl-2,2,6-trimethyl-7-oxabicyclo[2.2.1]heptane of formula IV is obtained by reacting the ketone of the formula II with dichloromethyllithium, which can be prepared by metallation of dichloromethane with butyllithium or lithium diisopropylamide.

Abstract: There is provided an sealant made with an isocyanate or hydroxyl terminated prepolymer made by reacting a stoichiometric excess of an organic polyisocyanate with polyols made of at least a polyoxyalkylene polyether triol or a mixture thereof with a polyoxyalkylene polyether diol. The triol or diol has within its structure the nucleus of an initiator compound, an internal blocks of oxypropylene groups, and external blocks of oxyalkylene groups, wherein the internal blocks of oxypropylene are between said nucleus and said external blocks, said external blocks are made of oxyalkylene groups derived from a C.sub.4 or higher alkylene oxide. The amount of the internal blocks of oxypropylene groups is from 25 weight percent to 80 weight percent based on the weight of all oxyalkylene groups and initiator in the prepolymer The triol or diol has a compatibility index of 25.degree. C. or less, and may be part of a two component or a one component moisture cured sealant.

Abstract: The use of a thermoplastic molding composition differing from ABS and comprising, based on a total of 100% by weight of amounts of components A and B, and, if desired, C and/or D,a: as component A, from 1 to 99% by weight, preferably from 15 to 60% by weight, in particular from 25 to 50% by weight, of a particulate emulsion polymer with a glass transition temperature of below 0.degree. C. and with a median particle size of from 50 to 1000 nm, preferably from 50 to 500 nm,b: as component B, from 1 to 99% by weight, preferably from 40 to 85% by weight, in particular from 50 to 75% by weight, of at least one amorphous or partly crystalline polymer,c: as component C, from 0 to 50% by weight of polycarbonates, andd: as component D, from 0 to 50% by weight of fibrous or particulate fillers or mixtures of thesefor producing covering grid plates for ventilator openings.

Abstract: The invention relates to a regulatory nucleic acid fragment from Ustilago maydis and to its use.

Abstract: The present invention provides compositions and methods for the treatment of cancer in a subject wherein compounds of Formula I as defined herein in combination with paclitaxel, taxotere or modified taxane or taxoid analogs provide enhanced anticancer effects over the effects achieved with the individual compounds.

Abstract: Carboxylic acid derivatives of the formula I ##STR1## where the radicals have the meanings stated in the description, and the preparation of these agreements [sic] and their use as drugs are described.